Cargando…
Inflammatory bowel disease and risk of idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis
INTRODUCTION: Inflammatory bowel disease is a relapsing chronic gastrointestinal inflammatory disease. Idiopathic pulmonary fibrosis is a rare but serious extraintestinal pulmonary manifestation of inflammatory bowel disease. However, the relationship between these two conditions is unclear. Therefo...
Autores principales: | Wang, Jiali, Kou, Fushun, Han, Xiao, Shi, Lei, Shi, Rui, Wang, Zhibin, Mao, Tangyou, Li, Junxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232144/ https://www.ncbi.nlm.nih.gov/pubmed/35749541 http://dx.doi.org/10.1371/journal.pone.0270297 |
Ejemplares similares
-
Protective Effect of Qingchang Wenzhong Decoction on Colitis and Colitis-Related Carcinogenesis by Regulating Inflammation and Intestinal Fibrosis
por: Cheng, Yuan, et al.
Publicado: (2023) -
Tongxie Anchang Decoction Relieves Visceral Hypersensitivity in Diarrhea-Predominant Irritable Bowel Syndrome Rats by Regulating the NGF/TrkA Signaling Pathway
por: Tan, Xiang, et al.
Publicado: (2021) -
Network Pharmacology Identifies the Mechanisms of Action of Tongxie Anchang Decoction in the Treatment of Irritable Bowel Syndrome with Diarrhea Predominant
por: Tan, Xiang, et al.
Publicado: (2020) -
Protocol for long-term effect of pulmonary rehabilitation under nintedanib in idiopathic pulmonary fibrosis
por: Nishiyama, Osamu, et al.
Publicado: (2021) -
Multiform-based Baduanjin exercise prevention and treatment for idiopathic pulmonary fibrosis: study protocol for a randomized controlled trial
por: Wu, Zenan, et al.
Publicado: (2023)